MTP & TEG/ROTEM Hardened Clinical Simulation Engine

Select Patient Clinical Condition Preset

Loading a condition presets the patient's vitals, labs, and underlying baseline clotting parameters.

Zone 1: Live Patient Vital Signs & Component Matrix

Heart Rate

135 bpm

Blood Pressure

82/44 mmHg

Hemoglobin

6.2 g/dL

Platelets

45k /µL

Fibrinogen

110 mg/dL

Prothrombin (INR)

1.90

aPTT Assay

58.0 s

PRBC Units 0 U

Packed Red Blood Cells. Expands volume but dilutes factors/platelets.

FFP Units 0 U

Fresh Frozen Plasma. Replaces clotting factors, shortening R-time.

Platelet Units 0 U

Pooled Platelets. Directly escalates maximum amplitude (MA).

Pharmacological Adjuvants

Targeted interventions to bypass or arrest specific pathways.

Tranexamic Acid (TXA) Antifibrinolytic; prevents late-phase clot tail collapse.

Cryoprecipitate Concentrates fibrinogen; boosts Alpha Angle & minor MA.

Calcium Chloride Reverses citrate toxicity; optimizes kinetics and hemodynamics.

Zone 2: Real-Time Viscoelastic Waveform Rendering (Accelerated)

R: 14.0 min

K: 6.0 min

α: 35.0°

MA: 38.0 mm

LY30: 2.5%

R Phase (Reaction Time)

K Phase & α Angle

Maximum Amplitude (MA)

Fibrinolysis (LY30)

Status: Initialising...

Zone 3: Diagnostic Engine & Clinical Guidance Feedback

⚠️

Acute Traumatic Coagulopathy (ATC)

Severe baseline systemic hemorrhage. The trace shows prolonged reaction time (R) indicating immediate clotting factor depletion, shallow alpha angle showing slow fibrin buildup, and severely reduced overall structural clot strength (MA).

Suggested Treatment: Initiate balanced 1:1:1 or 1:1:2 blood ratio deployment. Prioritize FFP and Cryoprecipitate to fix the kinetic phase.